David A. Siegel Dare Bioscience, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.42 - $2.09 $48,848 - $71,896	-34,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $48,848 - $73,272	34,400 New	34,400 $69,000
Q3 2021 Nov 15, 2021	SELL	$1.42 - $2.0 $46,860 - $66,000	-33,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.21 - $1.89 $110,836 - $173,124	-91,600 Reduced 73.52%	33,000 $62,000
Q1 2021 May 17, 2021	BUY	$1.31 - $3.0 $11,790 - $27,000	9,000 Added 7.79%	124,600 $211,000

Q4 2020 Feb 16, 2021	BUY	$0.96 - $1.51 $110,976 - $174,556	115,600 New	115,600 $155,000

6.86M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.